138 related articles for article (PubMed ID: 38220473)
1. Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help.
Janssens FV; Meijers B; François K
Semin Nephrol; 2023 Nov; 43(6):151483. PubMed ID: 38220473
[TBL] [Abstract][Full Text] [Related]
2. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
François K; Wissing KM; Jacobs R; Boone D; Jacobs K; Tielemans C
BMC Nephrol; 2014 Jul; 15():104. PubMed ID: 24993584
[TBL] [Abstract][Full Text] [Related]
3. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
Ryckelynck JP; Chouraqui D; Lobbedez T
Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
[TBL] [Abstract][Full Text] [Related]
4. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
[TBL] [Abstract][Full Text] [Related]
5. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate.
Evenepoel P; Maes B; Vanwalleghem J; Kuypers D; Messiaen T; Vanrenterghem Y
Am J Kidney Dis; 2002 Feb; 39(2):315-23. PubMed ID: 11840372
[TBL] [Abstract][Full Text] [Related]
6. Dialyzer Performance During Hemodialysis Without Systemic Anticoagulation Using a Heparin-Grafted Dialyzer Combined With a Citrate-Enriched Dialysate: Results of the Randomized Crossover Noninferiority EvoCit Study.
François K; De Clerck D; Tonnelier A; Cambier ML; Orlando C; Jochmans K; Cools W; Wissing KM
Am J Kidney Dis; 2022 Jan; 79(1):79-87.e1. PubMed ID: 33940113
[TBL] [Abstract][Full Text] [Related]
7. Hemodialysis without systemic anticoagulation: a prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding.
Guéry B; Alberti C; Servais A; Harrami E; Bererhi L; Zins B; Touam M; Joly D
PLoS One; 2014; 9(5):e97187. PubMed ID: 24825343
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for people receiving long-term haemodialysis.
Natale P; Palmer SC; Ruospo M; Longmuir H; Dodds B; Prasad R; Batt TJ; Jose MD; Strippoli GF
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD011858. PubMed ID: 38189593
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.
Islam MS; Hassan ZA; Chalmin F; Vido S; Berrada M; Verhelst D; Donnadieu P; Moranne O; Esnault VL
Am J Kidney Dis; 2016 Nov; 68(5):752-762. PubMed ID: 27344212
[TBL] [Abstract][Full Text] [Related]
10. What are the anticoagulation options for intermittent hemodialysis?
Davenport A
Nat Rev Nephrol; 2011 Jul; 7(9):499-508. PubMed ID: 21727925
[TBL] [Abstract][Full Text] [Related]
11. Heparin-coated dialyzer membranes: is non-inferiority good enough?
Meijers BK; Poesen R; Evenepoel P
Kidney Int; 2014 Dec; 86(6):1084-6. PubMed ID: 25427085
[TBL] [Abstract][Full Text] [Related]
12. Detection and Scoring of Extracorporeal Circuit Clotting During Hemodialysis.
Vanommeslaeghe F; Van Biesen W; François K
Semin Nephrol; 2023 Nov; 43(6):151474. PubMed ID: 38267348
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.
Rossignol P; Dorval M; Fay R; Ros JF; Loughraieb N; Moureau F; Laville M
Trials; 2013 Jun; 14():163. PubMed ID: 23725299
[TBL] [Abstract][Full Text] [Related]
14. Optimization of heparin anticoagulation for hemodialysis.
Davenport A
Hemodial Int; 2011 Oct; 15 Suppl 1():S43-8. PubMed ID: 22093600
[TBL] [Abstract][Full Text] [Related]
15. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
[TBL] [Abstract][Full Text] [Related]
16. Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs.
Francey T; Schweighauser A
J Vet Intern Med; 2018 Jan; 32(1):147-156. PubMed ID: 29171099
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation during haemodialysis in patients at high-risk of bleeding.
Kim YG
Nephrology (Carlton); 2003 Oct; 8 Suppl():S23-7. PubMed ID: 15012687
[TBL] [Abstract][Full Text] [Related]
19. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
20. Expanded hemodialysis: Is anticoagulation of the dialysis circuit different from online hemodiafiltration and high-flux hemodialysis?
Santos A; Macías N; Vega A; Abad S; Linares T; Aragoncillo I; Cruzado L; Pascual C; Goicoechea M; López-Gómez JM
Ther Apher Dial; 2022 Feb; 26(1):147-153. PubMed ID: 33890717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
